Abstract: A spring loaded fishing pole assembly for increasing the casting distance of a fishing lure includes a handle that has a first socket therein. An extension rod releasably engaging the first socket and the extension rod has a second socket therein. A fishing pole is provided that has a plurality of coils formed therein to define a coiled section of the fishing pole. The fishing pole releasably engages the second socket. Moreover, the fishing pole is comprised of a resiliently bendable material thereby facilitating the coiled section to whip the fishing pole when the fishing pole is cast. In this way the fishing pole increases a casting distance of a lure.

Abstract: Software and a system created by the software with its application are applied in the healthcare setting for various patients corresponding to the CMS or JCAHO core measures. The software and its system captures necessary patient data related to future P4P initiatives designed by federal authorities, private payors or other organizations plus report safety events. The software allows real-time data entry at the bedside, during patient care processes, from admission to discharge. The system provides real-time feedback to practitioners on their performance as well as hospital benchmarking. The software can be used on a variety of hardware devices, and may gather data from various hospital information systems.

Abstract: A method for the treatment of depleted intracellular and serum magnesium levels by administration of a highly bioavailable magnesium salt is disclosed. A prescription dispensing system is also disclosed. The highly bioavailable magnesium salt can be administered alone or as adjunctive therapy in conjunction with various medications that cause or exacerbate depleted intracellular magnesium levels, such as renal magnesium wasting medications, including diuretics, immunosuppressants, chemotherapeutic agents, and antibiotics. The highly bioavailable magnesium salt can also be used as adjunctive therapy in conjunction with Class III anti-arrhythmic drugs to attenuate the QTc interval and reduce the risk of fatal arrhythmias, which are a common risk associated with Class III anti-arrhythmic drugs.

Abstract: A method for the treatment of depleted intracellular and serum magnesium levels by administration of a highly bioavailable magnesium salt is disclosed. A prescription dispensing system is also disclosed. The highly bioavailable magnesium salt can be administered alone or as adjunctive therapy in conjunction with various medications that cause or exacerbate depleted intracellular magnesium levels, such as renal magnesium wasting medications, including diuretics, immunosuppressants, chemotherapeutic agents, and antibiotics. The highly bioavailable magnesium salt can also be used as adjunctive therapy in conjunction with Class III anti-arrhythmic drugs to attenuate the QTc interval and reduce the risk of fatal arrhythmias, which are a common risk associated with Class III anti-arrhythmic drugs.